LIVE Public of India  •  Pan-India Citizen Newsroom  •  Verified Reporting
support@publicofindia.in Membership
BREAKING
Submit your story — verified, policy-led, privacy-first publishing Hindi & English news updated every 15 minutes from across India Members get priority review, profile badge & creator dashboard Public of India is a private platform — not a government website Submit your story — verified, policy-led, privacy-first publishing Hindi & English news updated every 15 minutes from across India Members get priority review, profile badge & creator dashboard Public of India is a private platform — not a government website
Home  /  BUSINESS  /  Symbiotec Pharmalab IPO: Pharma Company’s Issue...
BUSINESS Verified

Symbiotec Pharmalab IPO: Pharma Company’s Issue Booked 70%, GMP Hints At Strong Debut - Should You Apply

India 13h ago Source: publicofindia

Get details on the Rs 1,757-crore Symbiotec Pharmalab IPO. Check GMP, price band, financials, and review to decide if you should apply today.

This is a summary. For the full story, refer to the original source. Public of India presents verified citizen-relevant reporting.